Cardiovascular Metabolic Syndrome: Mediators Involved in the Pathophysiology from Obesity to Coronary Heart Disease
Key result
This review evaluates several mediators from the pathophysiologic pathway from obesity to coronary heart disease for their applicability as biomarkers for early identification of cardiovascular risk.
Population
Patients with obesity and diabetes mellitus at increased risk for cardiovascular events
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
May inform early CHD risk assessment in obesity; leaves open prospective validation before clinical use.
Structured PICO
P
Population
Patients with obesity and diabetes mellitus at increased risk for cardiovascular events
I
Intervention
Biomarkers/mediators for early identification of coronary heart disease
This review highlights the pathophysiologic pathway from obesity to coronary heart disease and evaluates potential biomarkers for early identification of CHD in high-risk patients.
Cite This Study
Roos et al. (2012) conducted a review in Cardiovascular Metabolic Syndrome, Obesity, Coronary Heart Disease. Biomarkers was evaluated. This review evaluates several mediators from the pathophysiologic pathway from obesity to coronary heart disease for their applicability as biomarkers for early identification of cardiovascular risk.